Acquired refractory idiopathic aplastic anemia
Showing 26 - 50 of >10,000
Autoimmune Hemolytic Anemia, Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia Trial in Beijing (combination of a
Recruiting
- Autoimmune Hemolytic Anemia
- Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia
- combination of a single dose anti-CD20 antibody and bortezomib
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Oct 12, 2021
Autoimmune Diseases, Inflammatory Disease, Acquired Bone Marrow Aplasia Trial (Blood sample taken at a single time point)
Not yet recruiting
- Autoimmune Diseases
- +10 more
- Blood sample taken at a single time point
- (no location specified)
Sep 14, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +36 more
- Cyclophosphamide
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 23, 2023
Anemia, Aplastic, Anemia, Hypoplastic, Thrombocytopenia Trial run by the NHLBI (Eltrombopag)
Completed
- Anemia, Aplastic
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 30, 2020
Acquired Aplastic Anemia Trial in Moscow (Eltrombopag, IST (ATG + CsA))
Recruiting
- Acquired Aplastic Anemia
- Eltrombopag
- IST (ATG + CsA)
-
Moscow, Russian FederationDmitry Rogachev National Research Center of Pediatric Hematology
Mar 12, 2021
Aplastic Anemia, Aplastic Anemia Idiopathic Trial (Bone marrow cellularity by mDixon-quant)
Not yet recruiting
- Aplastic Anemia
- Aplastic Anemia Idiopathic
- Bone marrow cellularity by mDixon-quant
- (no location specified)
Feb 20, 2021
Non Severe Aplastic Anemia Trial in Beijing (Romiplostim, Ciclosporin)
Not yet recruiting
- Non Severe Aplastic Anemia
-
Beijing, ChinaPeking union medical college hospital
Aug 18, 2023
Severe Aplastic Anemia, Refractory, Severe Aplastic Anemia, Relapse Trial run by the NHLBI (Alemtuzumab (Campath ),
Completed
- Severe Aplastic Anemia, Refractory
- Severe Aplastic Anemia, Relapse
- Alemtuzumab (Campath )
- Cyclosporine
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 29, 2020
Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with
Recruiting
- Acute Leukemia
- +27 more
- HSCT with TBI Regimen
- HSCT with Non-TBI Regimen
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Apr 12, 2022
Aplastic Anemia, Drug Effect Trial in Beijing (Tacrolimus, Placebo (for Tacrolimus), Cyclosporin A)
Not yet recruiting
- Aplastic Anemia
- Drug Effect
- Tacrolimus
- +2 more
-
Beijing, ChinaPeking union medical college hospital
Jun 14, 2020
Non Severe Aplastic Anemia, Untreated Trial in China (Herombopag)
Recruiting
- Non Severe Aplastic Anemia
- Untreated
-
Tangshan, Hebei, China
- +3 more
Dec 14, 2022
Severe Aplastic Anemia Trial in United States (drug, procedure, radiation)
Active, not recruiting
- Severe Aplastic Anemia
- cyclosporine
- +8 more
-
Los Angeles, California
- +12 more
Feb 10, 2022
Severe Aplastic Anemia Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Sirolimus)
Recruiting
- Severe Aplastic Anemia
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Severe Aplastic Anemia Trial in United States (drug, radiation, procedure)
Completed
- Severe Aplastic Anemia
- Antithymocyte Globulin (ATG)
- +7 more
-
Duarte, California
- +27 more
Jul 21, 2022
Aplastic Anemia Trial in Tianjin (Avatrombopag 20 MG Oral Tablet)
Recruiting
- Aplastic Anemia
- Avatrombopag 20 MG Oral Tablet
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital, Chinese Acade
Oct 4, 2022
Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial run
Recruiting
- Severe Aplastic Anemia (SAA)
- +2 more
- Cyclophosphamide
- Peripheral Blood Stem Cells
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 28, 2023
Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)
Completed
- Chronic Myeloproliferative Disorders
- +5 more
- sargramostim
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 3, 2022
Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With
Active, not recruiting
- Adult Acute Lymphoblastic Leukemia in Remission
- +46 more
- Fludarabine
- +8 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 10, 2021
Severe Aplastic Anemia Trial run by the NHLBI (Cohort 1: hATG, CsA, EPAG Day 14 to Month 6, Cohort 2: hATG, CsA, EPAG Day 14 to
Recruiting
- Severe Aplastic Anemia
- Cohort 1: hATG, CsA, EPAG Day 14 to Month 6
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 5, 2022
Moderate Aplastic Anemia, Unilineage Bone Marrow Failure Disorders Trial run by the NHLBI (Eltrombopag)
Active, not recruiting
- Moderate Aplastic Anemia
- Unilineage Bone Marrow Failure Disorders
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 2, 2021
Severe Aplastic Anemia Trial in Tianjin (Avatrombopag)
Recruiting
- Severe Aplastic Anemia
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital, Chinese Acade
Jun 22, 2022
Bone Marrow Failure Syndrome, Severe Aplastic Anemia, Severe Congenital Neutropenia Trial in New York (CD34 Stem Cell Selection
Active, not recruiting
- Bone Marrow Failure Syndrome
- +15 more
- CD34 Stem Cell Selection Therapy
-
New York, New YorkMorgan Stanley Children's Hospital, New York-Presbyterian, Colum
Jun 17, 2020
ATGAM General Investigation
Not yet recruiting
- Aplastic Anemia
- Anti-human thymocyte immunoglobulin, equine
- (no location specified)
Sep 8, 2023
Hematological Disorders Associated With COVID-19 Infection
Completed
- Hematological Condition With COVID19
-
Assiut, EgyptFacility of medicine
Jan 6, 2023